
Job Overview
Location
Tacoma, WA
Job Type
Full-time
Category
Sales
Date Posted
April 21, 2026
Full Job Description
đź“‹ Description
- • As a Prenatal Account Executive at BilliontoOne, you will drive the adoption of the company’s groundbreaking UNITY Fetal Risk Screen — the first and only single-gene NIPT that combines carrier and aneuploidy screening — by selling directly to OBGYNs, maternal-fetal medicine specialists, and genetic counselors in the Tacoma territory. Your role is critical in expanding access to life-changing prenatal diagnostics that empower physicians and patients with actionable genetic insights, directly supporting BilliontoOne’s mission to make transformative molecular diagnostics accessible to all.
- • Day to day, you will prospect, cultivate, and manage relationships with healthcare providers; deliver clinical and product information to external clients and internal teams; attend industry events and conferences; develop and execute strategic business plans to grow test utilization; and oversee the full sales lifecycle from lead generation to closing business, all while ensuring compliance with HIPAA and ethical standards in handling sensitive patient and physician data.
- • You will join a mission-driven, innovative team of scientists, engineers, and sales professionals united by a commitment to redefining prenatal and cancer diagnostics. BilliontoOne is a publicly traded Nasdaq company recognized as a Forbes Best Startup Employer and Great Place to Work certified, with over 700 employees and a culture built on transparency, collaboration, and scientific excellence.
- • In this role, you will develop deep expertise in molecular diagnostics and women’s health sales, sharpen your strategic and consultative selling skills, and have the opportunity to significantly impact patient outcomes while earning uncapped commissions and equity in a high-growth, purpose-led organization.
Skills & Technologies
About BilliontoOne
BilliontoOne is a biotechnology company focused on developing advanced diagnostic tools. Their core technology leverages single-molecule analysis to detect rare biological events, such as circulating tumor DNA (ctDNA) in blood. This enables highly sensitive and early cancer detection, potentially transforming cancer screening and monitoring. The company aims to provide non-invasive methods for personalized medicine, allowing for earlier intervention and improved patient outcomes. Their platform is designed for broad applicability across various cancer types and stages, offering a significant advancement in the field of liquid biopsy and precision oncology.
Subscribe to the weekly newsletter for similar remote roles and curated hiring updates.
Newsletter
Weekly remote jobs and featured talent.
No spam. Only curated remote roles and product updates. You can unsubscribe anytime.
Similar Opportunities

Awin Group AG
8 days ago

Ontic Technologies, Inc.
11 days ago

